Aflibercept group:None

2 trials

Sponsors

Sichuan Academy of Medical Sciences Sichuan Provincial People's Hospital, Zhongshan Hospital, Fudan University

Conditions

Age-related macular degenerationage-related macular degeneration

Unknown Phase

Application of artificial intelligence based on deep learning in the diagnosis and treatment of age-related macular degeneration

Active, not recruitingChiCTR2400093122

Sichuan Academy of Medical Sciences Sichuan Provincial People's Hospitalage-related macular degeneration

Start: 2023-12-01Updated: 2024-12-02

Target Trial Emulation Framework for Comparing Early Efficacy of Faricimab and Aflibercept In the Treatment of Patients With Neovascular Age-Related Macular Degeneration With Pigment Epithelium Detachment

Active, not recruitingChiCTR2600118980

Zhongshan Hospital, Fudan UniversityAge-related macular degeneration

Start: 2026-03-01Updated: 2026-02-16